4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Recordati Industria Chimica e Farmaceutica S.p.A. (REC) operates in the Drug Manufacturers - General industry and is headquartered in Milan, Italy with about 4,700 employees. Its market capitalization is roughly €11 billion. In the fiscal year ended 2025-12-31, REC reported €2.6B in revenue and €444M in net income.
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
Interactive charts & full statements → Open the REC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €2.6B | €2.3B | €2.1B | €1.9B | — |
| Gross Profit | €1.8B | €1.6B | €1.4B | €1.3B | — |
| Operating Income (EBIT) | €720M | €660M | €566M | €494M | — |
| Net Income | €444M | €416M | €389M | €312M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | €697M | €713M | €662M | €632M | €644M | — |
| Gross Profit | €498M | €511M | €473M | €432M | €424M | — |
| Operating Income (EBIT) | €204M | €232M | €192M | €181M | €150M | — |
| Net Income | €117M | €153M | €117M | €110M | €91M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€268M) | (€254M) | (€246M) | (€231M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Dividends Paid | (€143M) | (€0M) | (€129M) | (€1M) | (€136M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €5.3B | €5.1B | €4.2B | €4.0B | — |
| Total Liabilities | €3.3B | €3.3B | €2.5B | €2.5B | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive REC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms